Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
Adrenaline; Lignocaine hydrochloride
Specialites Septodont Pty Ltd
Medicine Registered
VARIATION TO THE REGISTRATION OF LIGNOSPAN SPECIAL Specialites Septodont June 2003 File: Septo/Lidocaine/Lignospan submission / lignospan CMI June03-V04 - 1 - LIGNOSPAN SPECIAL WHAT’S IN YOUR MEDICINE ACTIVE INGREDIENTS Cartridge 2.2 mL 1.8 mL Lignocaine hydrochloride 44 mg 36 mg Adrenaline (as acid tartrate) 27.5 µg 22.5 µg OTHER INGREDIENTS: Sodium chloride, sodium hydroxide, disodium edetate, potassium metabisulfite, water for injections. PRESENTATION: Box of 50 cartridges single use, containing each 2.2 mL or 1.8 mL of solution. WHAT YOUR MEDICINE IS USED FOR AND HOW IT WORKS LIGNOSPAN SPECIAL is given by injection to cause loss of feeling before and during dental procedures. It contains two active ingredients: Lignocaine hydrochloride, a local anaesthetic to prevent the pain, and adrenaline tartrate, a vasoconstrictor, which makes it, last longer (Adrenaline narrows the blood vessels at the site of injection, which keeps the anaesthetic where it’s needed for a longer time) and controls bleeding during the surgery. ADVICE BEFORE USING THE MEDICINAL PRODUCT In deciding to use a medicine, the risks of using the medicine must be weighed against the good it will do. This is a decision you and your dentist will make. For local anaesthetics, the following should be considered. THIS PRODUCT SHOULD NOT BE USED IF: - You are allergic to • adrenaline • lignocaine, procaine or any local anaesthetic • sodium metabisulfite or any sulfites • any other ingredient included in the product. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing: swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. - You have ar Đọc toàn bộ tài liệu
VARIATION TO THE REGISTRATION OF A DRUG PRODUCT Specialites Septodont July 2003 Septo / Lidocaine/ lignospan submission / Lignospan PI-July03-V05 .H 2 O DESCRIPTION LIGNOSPAN SPECIAL contains a local anaesthetic of amide type, lignocaine hydrochloride (2%), combined with a vasoconstrictor, adrenaline tartrate (1/80.000). LIGNOCAINE HYDROCHLORIDE CAS [6108-05-0] Mr: 288.8 Local and regional anaesthetic C 14 H 23 ClN 2 O.H 2 O 2-diethylaminoaceto-2’6’-xylidide hydrochloride monohydrate White crystalline powder practically odourless. Lignocaine hydrochloride is very soluble in water, freely soluble in ethanol, and practically insoluble in ether. ADRENALINE ACID TARTRATE CAS [51-42-3] Mr: 333.3 C 13 H 19 NO 9 (R)-1-(3,4-di-hydroxyphenyl)-2-methylaminoethanol hydrogen tartrate White to greyish-white or light brownish-grey, odourless, crystalline powder. Adrenaline acid tartrate 1.8 mg is approximately equivalent to 1 mg of adrenaline. Cartridge 2.2 mL 1.8 mL Lignocaine hydrochloride .............................................44 mg 36 mg Adrenaline .....................................................................27.5 µg 22.5 µg (as acid tartrate) Sodium chloride ............................................................14.3 mg 11.7 mg Potassium metabisulfite ................................................2.64 mg 2.16 mg Disodium edetate ..........................................................0.55 mg 0.45 mg Sodium hydroxide solution (to adjust pH) (to adjust pH) Water for injection q.s. ad .............................................2.2 mL 1.8 mL For single patient use only. Contains no anti-microbial agent. Discard unused contents after use. PHARMACOLOGY PHARMACODYNAMICS Lignocaine stabilises the neuronal membrane by decreasing its permeability to sodium ions and reversibly blocks the initiation and conduction of nerve i Đọc toàn bộ tài liệu